CHAMPIONS ONCOLOGY, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$176.00 thousand for the 9-month period ending 2016-01-31, per its 10-Q filed 2016-03-16.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2016-03-16
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-01-31 was -$132.00K.
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-10-31 was -$15.00K.
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-07-31 was -$29.00K.
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-04-30 was -$30.00K.
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$114.00K.
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$234.00K.
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$57.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2016-01-31 | -$132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | -$147.00K derived: sum of 2 quarters · filed 2016-03-16 | -$176.00K 10-Q · filed 2016-03-16 | -$206.00K derived: sum of 4 quarters · filed 2016-03-16 |
| 2015-10-31 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-15 | -$44.00K 10-Q · filed 2015-12-15 | -$74.00K derived: sum of 3 quarters · filed 2015-12-15 | -$87.00K derived: sum of 4 quarters · filed 2016-03-16 |
| 2015-07-31 | -$29.00K 10-Q · filed 2015-09-11 | -$59.00K derived: sum of 2 quarters · filed 2015-09-11 | -$72.00K derived: sum of 3 quarters · filed 2016-03-16 | -$110.00K derived: sum of 4 quarters · filed 2016-03-16 |
| 2015-04-30 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | -$43.00K derived: sum of 2 quarters · filed 2016-03-16 | -$81.00K derived: sum of 3 quarters · filed 2016-03-16 | -$114.00K 10-K · filed 2015-07-29 |
| 2015-01-31 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | -$51.00K derived: sum of 2 quarters · filed 2016-03-16 | -$84.00K 10-Q · filed 2016-03-16 | -$154.00K derived: sum of 4 quarters · filed 2016-03-16 |
| 2014-10-31 | -$38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-15 | -$71.00K 10-Q · filed 2015-12-15 | -$141.00K derived: sum of 3 quarters · filed 2015-12-15 | -$229.00K derived: sum of 4 quarters · filed 2015-12-15 |
| 2014-07-31 | -$33.00K 10-Q · filed 2015-09-11 | -$103.00K derived: sum of 2 quarters · filed 2015-09-11 | -$191.00K derived: sum of 3 quarters · filed 2015-09-11 | -$227.00K derived: sum of 4 quarters · filed 2015-09-11 |
| 2014-04-30 | -$70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | -$158.00K derived: sum of 2 quarters · filed 2015-07-29 | -$194.00K derived: sum of 3 quarters · filed 2015-07-29 | -$234.00K 10-K · filed 2015-07-29 |
| 2014-01-31 | -$88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | -$124.00K derived: sum of 2 quarters · filed 2015-03-17 | -$164.00K 10-Q · filed 2015-03-17 | -$186.00K derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-10-31 | -$36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | -$76.00K 10-Q · filed 2014-12-15 | -$98.00K derived: sum of 3 quarters · filed 2014-12-15 | |
| 2013-07-31 | -$40.00K 10-Q · filed 2014-09-12 | -$62.00K derived: sum of 2 quarters · filed 2014-09-12 | ||
| 2013-04-30 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28 | -$57.00K 10-K · filed 2014-07-28 | ||
| 2013-01-31 | -$35.00K 10-Q · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |